RADNOR, Pa., Sept. 6, 2011 (GLOBE NEWSWIRE) -- PolyMedix, Inc. (OTCBB:PYMX), an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and life-threatening infectious diseases, will be presenting at the Rodman & Renshaw Global Investment Conference. The Conference will take place September 12-13, 2011 at the Waldorf-Astoria in New York, NY.
